These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 37038248)
1. Perspectives toward cannabidiol (CBD) among youth in Early Psychosis Intervention programs: A qualitative study. Ghelani A Early Interv Psychiatry; 2024 Jan; 18(1):10-17. PubMed ID: 37038248 [TBL] [Abstract][Full Text] [Related]
2. Cannabidiol, but Not Δ9-Tetrahydrocannabinol, Has Strain- and Genotype-Specific Effects in Models of Psychosis. Mielnik CA; Li CK; Ramsey AJ; Salahpour A; Burnham WM; Ross RA Cannabis Cannabinoid Res; 2024 Feb; 9(1):174-187. PubMed ID: 36251462 [No Abstract] [Full Text] [Related]
3. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis. Hahn B Schizophr Bull; 2018 Jan; 44(1):46-53. PubMed ID: 29083450 [TBL] [Abstract][Full Text] [Related]
4. Cannabidiol as a potential treatment for psychosis. Schubart CD; Sommer IE; Fusar-Poli P; de Witte L; Kahn RS; Boks MP Eur Neuropsychopharmacol; 2014 Jan; 24(1):51-64. PubMed ID: 24309088 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of the antipsychotic properties of cannabidiol in humans. Iseger TA; Bossong MG Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194 [TBL] [Abstract][Full Text] [Related]
6. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112 [TBL] [Abstract][Full Text] [Related]
7. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History. Berl V; Hurd YL; Lipshutz BH; Roggen M; Mathur EJ; Evans M Cannabis Cannabinoid Res; 2022 Dec; 7(6):777-789. PubMed ID: 35787693 [No Abstract] [Full Text] [Related]
8. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study. Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109 [TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
10. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients. Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA Front Public Health; 2022; 10():893009. PubMed ID: 35784239 [TBL] [Abstract][Full Text] [Related]
11. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada. Hammond D; Goodman S Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866 [No Abstract] [Full Text] [Related]
12. Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Freeman TP; Craft S; Wilson J; Stylianou S; ElSohly M; Di Forti M; Lynskey MT Addiction; 2021 May; 116(5):1000-1010. PubMed ID: 33160291 [TBL] [Abstract][Full Text] [Related]
13. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Fernández N; Cappello MG; Quiroga PN Forensic Sci Int; 2023 Aug; 349():111762. PubMed ID: 37392612 [TBL] [Abstract][Full Text] [Related]
14. The Yin and Yang of Cannabis: A Systematic Review of Human Neuroimaging Evidence of the Differential Effects of Δ Gunasekera B; Davies C; Martin-Santos R; Bhattacharyya S Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):636-645. PubMed ID: 33414100 [TBL] [Abstract][Full Text] [Related]
15. Homegrown perceptions about the medical use and potential abuse of CBD and THC. McFadden BR; Malone T Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977 [TBL] [Abstract][Full Text] [Related]
16. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity. Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455 [TBL] [Abstract][Full Text] [Related]
17. The relationship between cannabidiol and psychosis: A review. Silva TB; Balbino CQ; Weiber AF Ann Clin Psychiatry; 2015 May; 27(2):134-41. PubMed ID: 25954940 [TBL] [Abstract][Full Text] [Related]